CoagulationDisorders near Ocala, FL

Biography: Interests Lung Cancer Esophageal Cancer Medical Education Quality of Care

Care Philosophy: At Moffitt Cancer Center we are working tirelessly in the areas of patient care research and education to advance one step further in fighting cancer As a National Cancer Institute designated Comprehensive Cancer Center we are committed to the health and safety of our patients and dedicated to providing expert cancer care From enhanced quality of life to complete remission Moffitt is Florida s top choice aiming to achieve the best outcome for each patient

Care Philosophy: Dr Doris Hansen is an Assistant Member in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy. Dr Hansen earned her MD from St. George's University School of Medicine, Grenada. She completed an Internal Medicine Residency and a Hematology/Oncology Fellowship at the University of Mississippi Medical Center in Jackson. Dr Hansen completed a Fellowship in Blood and Marrow Transplant and Cellular Immunotherapy at Moffitt Cancer Center. Dr Hansen's clinical interests include autologous and allogeneic hematopoietic stem cell transplantation for disease processes such as leukemia and multiple myeloma in addition to Chimeric Antigen Receptor Therapy (CAR-T) for plasma cell dyscrasias.

Care Philosophy: Dr Kirtane is an Assistant Member in the Department of Head and Neck-Endocrine Oncology and Medical Director for Solid Tumor Cellular Therapy. Dr Kirtane received his MD degree from The University of Florida College of Medicine. He completed an Internal Medicine Residency at Duke University Medical Center. Dr Kirtane completed a Hematology/Oncology Fellowship at the University of Washington and a Post-Doctoral Fellowship in Oncology at Fred Hutchinson Cancer Research Center. His clinical focus is patients with head and neck-endocrine cancers. He works on the development of innovative cellular therapies for solid tumor cancers and is focused on increasing representation of underrepresented groups to clinical trials.